BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11037552)

  • 1. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Brown RC
    Radiology; 2000 Jun; 215 Suppl():1363-72. PubMed ID: 11037552
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
    Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
    Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
    Graham MV; Byhardt RW; Sause WT; Curran WJ; Fuller D; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1347-62. PubMed ID: 11037551
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

  • 5. Staging of non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    Ko B; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Brown RC
    Radiology; 2000 Jun; 215 Suppl():1281-94. PubMed ID: 11037547
    [No Abstract]   [Full Text] [Related]  

  • 6. Staging of bronchogenic carcinoma, non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    McLoud TC; Westcott J; Davis SD; Fleishon H; Gefter WB; Henschke CI; Pugatch RD; Sostman HD; Tocino I; White CS; Yankelevitz D; Bode FR
    Radiology; 2000 Jun; 215 Suppl():611-9. PubMed ID: 11037472
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.
    Grunenwald DH; André F; Le Péchoux C; Girard P; Lamer C; Laplanche A; Tarayre M; Arriagada R; Le Chevalier T
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):796-802. PubMed ID: 11581616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is effective in non-small cell lung carcinoma?].
    Pneumologie; 1996 Jun; 50(6):X. PubMed ID: 8766369
    [No Abstract]   [Full Text] [Related]  

  • 9. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
    Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer].
    Wang W; Li H; Shang LQ; Li XC; Li J; Song WA; Wen F
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1450-2. PubMed ID: 16318812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Byhardt RW; Sause WT; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
    Radiology; 2000 Jun; 215 Suppl():1331-45. PubMed ID: 11037550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 13. ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
    Gopal RS; Dubey S; Rosenzweig KE; Chang JY; Decker R; Gewanter RM; Kong FM; Lally BE; Langer CJ; Lee HK; Movsas B
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):969-74. PubMed ID: 20813465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
    Sanuki-Fujimoto N; Sumi M; Ito Y; Imai A; Kagami Y; Sekine I; Kunitoh H; Ohe Y; Tamura T; Ikeda H
    Radiother Oncol; 2009 Jun; 91(3):433-7. PubMed ID: 19167118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.